Unknown

Dataset Information

0

Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.


ABSTRACT: Immune responses counteract infections but also cause collateral damage to hosts. Oligoadenylate synthetase 1 (OAS1) binds double-stranded RNA from invading viruses and produces 2'-5' linked oligoadenylate (2-5A) to activate ribonuclease L (RNase L), which cleaves RNA to inhibit virus replication. OAS1 can also undergo autoactivation by host RNAs, a potential trade-off to antiviral activity. We investigated functional variation in primate OAS1 as a model for how immune pathways evolve to mitigate costs and observed a surprising frequency of loss-of-function variation. In gorillas, we identified a polymorphism that severely decreases catalytic function, mirroring a common variant in humans that impairs 2-5A synthesis through alternative splicing. OAS1 loss-of-function variation is also common in monkeys, including complete loss of 2-5A synthesis in tamarins. The frequency of loss-of-function alleles suggests that costs associated with OAS1 activation can be so detrimental to host fitness that pathogen-protective effects are repeatedly forfeited.

SUBMITTER: Carey CM 

PROVIDER: S-EPMC6609161 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.

Carey Clayton M CM   Govande Apurva A AA   Cooper Juliane M JM   Hartley Melissa K MK   Kranzusch Philip J PJ   Elde Nels C NC  

Cell host & microbe 20190131 2


Immune responses counteract infections but also cause collateral damage to hosts. Oligoadenylate synthetase 1 (OAS1) binds double-stranded RNA from invading viruses and produces 2'-5' linked oligoadenylate (2-5A) to activate ribonuclease L (RNase L), which cleaves RNA to inhibit virus replication. OAS1 can also undergo autoactivation by host RNAs, a potential trade-off to antiviral activity. We investigated functional variation in primate OAS1 as a model for how immune pathways evolve to mitigat  ...[more]

Similar Datasets

| S-EPMC8357416 | biostudies-literature
| S-EPMC4809017 | biostudies-literature
| S-EPMC9937649 | biostudies-literature
| S-EPMC4740929 | biostudies-literature
| S-EPMC5371728 | biostudies-literature
| S-EPMC5173322 | biostudies-literature
| S-EPMC10069973 | biostudies-literature
| S-EPMC3341824 | biostudies-literature
| S-EPMC6096791 | biostudies-literature
| S-EPMC4349249 | biostudies-literature